Trials / Unknown
UnknownNCT04197180
Hybrid APC for Gastric Low Grade Intraepithelial Neoplasia
HybridAPC for the Treatment of Gastric Low Grade Intraepithelial Neoplasia (LGIN): a Prospective, Multi-center Study
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 100 (estimated)
- Sponsor
- Chinese University of Hong Kong · Academic / Other
- Sex
- All
- Age
- 18 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
This cohort study aims to investigate the clinical efficacy and safety of Hybrid APC for treatment of gastric low grade intramucosal neoplasia.
Detailed description
This cohort study aims to investigate the clinical efficacy and safety of Hybrid APC for treatment of gastric low grade intramucosal neoplasia. Successful ablation is defined as no evidence of local recurrence at 12 months after HybridAPC upon follow up endoscopy. This is defined as absence of LGIN, HGIN and cancer in biopsies obtained at all locations during followup endoscopy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Hybrid Argon Plasma Coagulation | Argon Plasma Coagulation after water injection for local ablation |
Timeline
- Start date
- 2020-03-01
- Primary completion
- 2024-12-31
- Completion
- 2024-12-31
- First posted
- 2019-12-12
- Last updated
- 2023-11-07
Locations
1 site across 1 country: Hong Kong
Source: ClinicalTrials.gov record NCT04197180. Inclusion in this directory is not an endorsement.